000 | 01899 a2200493 4500 | ||
---|---|---|---|
005 | 20250515203634.0 | ||
264 | 0 | _c20100618 | |
008 | 201006s 0 0 eng d | ||
022 | _a1522-726X | ||
024 | 7 |
_a10.1002/ccd.22346 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLinke, Axel | |
245 | 0 | 0 |
_aThe utility of trans-catheter aortic valve replacement after commercialization: does the European experience provide a glimpse into the future use of this technology in the United States? _h[electronic resource] |
260 |
_bCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions _cMar 2010 |
||
300 |
_a511-8 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article; Review | ||
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAortic Valve Stenosis _xeconomics |
650 | 0 | 4 |
_aCardiac Catheterization _xadverse effects |
650 | 0 | 4 |
_aCatheterization _xadverse effects |
650 | 0 | 4 | _aCommerce |
650 | 0 | 4 | _aDiffusion of Innovation |
650 | 0 | 4 | _aEurope |
650 | 0 | 4 | _aEvidence-Based Medicine |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHealth Care Costs |
650 | 0 | 4 | _aHeart Valve Prosthesis |
650 | 0 | 4 |
_aHeart Valve Prosthesis Implantation _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPatient Selection |
650 | 0 | 4 | _aProsthesis Design |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aUnited States |
700 | 1 | _aWalther, Thomas | |
700 | 1 | _aSchuler, Gerhard | |
773 | 0 |
_tCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions _gvol. 75 _gno. 4 _gp. 511-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/ccd.22346 _zAvailable from publisher's website |
999 |
_c19464891 _d19464891 |